Published in Front Neurol on April 08, 2015
Contribution of metabolic reprogramming to macrophage plasticity and function. Semin Immunol (2015) 0.90
Inflammatory Disequilibrium in Stroke. Circ Res (2016) 0.83
Distribution and Quantification of Choroidal Macrophages in Human Eyes With Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci (2016) 0.79
Prolonged diet-induced obesity in mice modifies the inflammatory response and leads to worse outcome after stroke. J Neuroinflammation (2015) 0.79
Glucose consumption of inflammatory cells masks metabolic deficits in the brain. Neuroimage (2015) 0.79
Reducing GABAA-mediated inhibition improves forelimb motor function after focal cortical stroke in mice. Sci Rep (2016) 0.77
Mannan binding lectin-associated serine protease-2 (MASP-2) critically contributes to post-ischemic brain injury independent of MASP-1. J Neuroinflammation (2016) 0.77
Microglia Transcriptome Changes in a Model of Depressive Behavior after Immune Challenge. PLoS One (2016) 0.77
In vivo inhibition of miR-155 significantly alters post-stroke inflammatory response. J Neuroinflammation (2016) 0.76
Fractalkine Receptor Deficiency Is Associated with Early Protection but Late Worsening of Outcome following Brain Trauma in Mice. J Neurotrauma (2015) 0.76
Sildenafil, a cyclic GMP phosphodiesterase inhibitor, induces microglial modulation after focal ischemia in the neonatal mouse brain. J Neuroinflammation (2016) 0.76
Polarizing the immune system towards neuroprotection in brain ischemia. Neural Regen Res (2016) 0.75
Microglia and Monocyte-Derived Macrophages in Stroke. Neurotherapeutics (2016) 0.75
Immunization with Cop-1 promotes neuroprotection and neurogenesis after ischemic stroke. Neural Regen Res (2015) 0.75
Blood/Brain Biomarkers of Inflammation After Stroke and Their Association With Outcome: From C-Reactive Protein to Damage-Associated Molecular Patterns. Neurotherapeutics (2016) 0.75
Targeting resolution of neuroinflammation after ischemic stroke with a lipoxin A4 analog: Protective mechanisms and long-term effects on neurological recovery. Brain Behav (2017) 0.75
Fumarate modulates the immune/inflammatory response and rescues nerve cells and neurological function after stroke in rats. J Neuroinflammation (2016) 0.75
Cell Surface CD36 Protein in Monocyte/Macrophage Contributes to Phagocytosis during the Resolution Phase of Ischemic Stroke in Mice. J Biol Chem (2016) 0.75
Neuroprotective Properties of a Macrolide Antibiotic in a Mouse Model of Middle Cerebral Artery Occlusion: Characterization of the Immunomodulatory Effects and Validation of the Efficacy of Intravenous Administration. Assay Drug Dev Technol (2016) 0.75
Myeloperoxidase Inhibition Increases Neurogenesis after Ischemic Stroke. J Pharmacol Exp Ther (2016) 0.75
Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke. Acta Neuropathol (2017) 0.75
Alternative activation of macrophages. Nat Rev Immunol (2003) 27.53
Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity (2003) 21.56
The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol (2004) 19.38
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol (2002) 17.85
Macrophage plasticity and polarization: in vivo veritas. J Clin Invest (2012) 13.44
Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol (2011) 12.21
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med (2004) 11.71
ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci (2005) 11.55
Cells lying on a bed of microneedles: an approach to isolate mechanical force. Proc Natl Acad Sci U S A (2003) 11.53
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med (2007) 11.51
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci (2007) 11.24
Macrophage activation and polarization. Front Biosci (2008) 11.17
Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci (2007) 11.11
Complement: a key system for immune surveillance and homeostasis. Nat Immunol (2010) 10.37
International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev (2001) 9.90
Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol (2006) 9.82
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol (2010) 9.59
Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science (2007) 9.54
HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell (2003) 9.12
The classical complement cascade mediates CNS synapse elimination. Cell (2007) 9.06
Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol (2005) 8.49
Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med (1992) 8.46
Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci (2006) 8.25
Hypoxia-inducible factors in physiology and medicine. Cell (2012) 8.16
Physiology of microglia. Physiol Rev (2011) 6.99
Identification of a factor that links apoptotic cells to phagocytes. Nature (2002) 6.76
The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature (2011) 6.71
Glial and neuronal control of brain blood flow. Nature (2010) 6.61
The immunology of stroke: from mechanisms to translation. Nat Med (2011) 6.53
Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron (2006) 6.38
Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol (2011) 6.34
Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature (2001) 6.31
The science of stroke: mechanisms in search of treatments. Neuron (2010) 6.14
Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron (2012) 5.84
Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci (2009) 4.83
Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J Immunol (2001) 4.59
Microglia as a source and target of cytokines. Glia (2002) 4.48
Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med (2005) 4.42
Other functions, other genes: alternative activation of antigen-presenting cells. Immunity (1999) 4.15
Identification of a unique TGF-β-dependent molecular and functional signature in microglia. Nat Neurosci (2013) 3.94
Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci (2007) 3.93
Transcriptional profiling reveals complex regulation of the monocyte IL-1 beta system by IL-13. J Immunol (2005) 3.87
The myeloid cells of the central nervous system parenchyma. Nature (2010) 3.80
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature (2007) 3.78
HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J Clin Invest (2005) 3.77
Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med (2003) 3.71
Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke (2009) 3.55
The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood (2003) 3.51
IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol (2009) 3.41
Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci (2011) 3.40
Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol (2011) 3.20
Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem (1992) 3.18
Cerebral microvessel responses to focal ischemia. J Cereb Blood Flow Metab (2003) 3.14
Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol (2009) 3.07
What is immune privilege (not)? Trends Immunol (2006) 3.02
Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc Natl Acad Sci U S A (2009) 3.01
The role of microglia in the healthy brain. J Neurosci (2011) 2.94
Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler Thromb Vasc Biol (2009) 2.80
Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease. Nat Neurosci (2010) 2.79
Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell (2014) 2.78
Arginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells. J Immunol (2005) 2.75
MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain (2009) 2.74
Microglia in health and disease. J Neurosci Res (2005) 2.74
Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci U S A (2008) 2.70
Differential roles of microglia and monocytes in the inflamed central nervous system. J Exp Med (2014) 2.68
Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol (2004) 2.46
The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol (1999) 2.46
Astrocyte metabolism and signaling during brain ischemia. Nat Neurosci (2007) 2.39
Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology (2000) 2.36
Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse. J Cereb Blood Flow Metab (2008) 2.33
Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci U S A (1996) 2.32
Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum Mol Genet (2008) 2.27
CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models. Am J Pathol (2010) 2.25
Regulation of tau pathology by the microglial fractalkine receptor. Neuron (2010) 2.24
Neuron-specific inactivation of the hypoxia inducible factor 1 alpha increases brain injury in a mouse model of transient focal cerebral ischemia. J Neurosci (2007) 2.24
Innate immune activation in neurodegenerative disease. Nat Rev Immunol (2014) 2.21
Trafficking of immune cells in the central nervous system. J Clin Invest (2010) 2.17
A role for Mer tyrosine kinase in alphavbeta5 integrin-mediated phagocytosis of apoptotic cells. J Cell Sci (2005) 2.15
Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol (2011) 2.14
Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J Neurosci (1999) 2.13
Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat Immunol (2006) 2.12
Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis. J Neuroimmunol (2007) 2.08
Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis. Circulation (2007) 2.06
Monocyte trafficking in acute and chronic inflammation. Trends Immunol (2011) 2.05
Cutting edge: biasing immune responses by directing antigen to macrophage Fc gamma receptors. J Immunol (2002) 2.02
CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity. J Neurosci (2011) 1.95
Human umbilical cord blood mesenchymal stem cells protect mice brain after trauma. Crit Care Med (2011) 1.95
A novel phenotype for an activated macrophage: the type 2 activated macrophage. J Leukoc Biol (2002) 1.91
Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation. Glia (2000) 1.88
CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-β phagocytosis. J Neurosci (2010) 1.88
Long-term accumulation of microglia with proneurogenic phenotype concomitant with persistent neurogenesis in adult subventricular zone after stroke. Glia (2009) 1.86
Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3. Scand J Immunol (2001) 1.86
Microglia regulate the number of neural precursor cells in the developing cerebral cortex. J Neurosci (2013) 1.86
Temporal pattern of expression and colocalization of microglia/macrophage phenotype markers following brain ischemic injury in mice. J Neuroinflammation (2011) 1.84
Crosstalk pathways between Toll-like receptors and the complement system. Trends Immunol (2010) 1.83
Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat Commun (2012) 1.82
Microglia provide neuroprotection after ischemia. FASEB J (2006) 1.82
Phagocytosis executes delayed neuronal death after focal brain ischemia. Proc Natl Acad Sci U S A (2013) 1.78
Brain-specific knock-out of hypoxia-inducible factor-1alpha reduces rather than increases hypoxic-ischemic damage. J Neurosci (2005) 1.75
Bradykinin-induced microglial migration mediated by B1-bradykinin receptors depends on Ca2+ influx via reverse-mode activity of the Na+/Ca2+ exchanger. J Neurosci (2007) 1.74